Pravastatin, an HMG-CoA Reductase Inhibitor, is Transported by Rat Organic Anion Transporting Polypeptide, Oatp2

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 1999 Jul 9

PMID 10397612

Citations 15

Authors

T Tokui

D Nakai

R Nakagomi

H Yawo

T Abe

Y Sugiyama

Affiliations

Soon will be listed here.

Abstract

Purpose: We previously demonstrated the HMG-CoA reductase inhibitor, pravastatin, is actively taken up into isolated rat hepatocytes through multispecific organic anion transporters. The present study examined whether a newly cloned organic anion transporting polypeptide (oatp2) transports pravastatin.

Methods: We investigated functional expression of oatp2 in Xenopus laevis oocytes, to examine [14C] pravastatin uptake.

Results: [14C] Pravastatin (30 microM) uptake into oatp2 cRNA-injected oocytes was 40 times higher than that of water-injected control oocytes. The oatp2-mediated pravastatin uptake was Na+-independent and saturable. The Michaelis-Menten constant was 37.5+/-9.9 microM, a level comparable to that obtained in isolated rat hepatocytes in our previous study. As is the case with rat hepatocytes, the uptake of pravastatin (30 microM) was inhibited by 300 microM concentrations of taurocholate, cholate, bromosulfophthalein, estradiol-17beta-glucuronide, and simvastatin acid, but not by para-aminohippurate. On the other hand, [14C] simvastatin acid (30 microM) uptake of oatp2 cRNA-injected oocytes was not significantly different from that of water-injected oocytes.

Conclusions: The cloned oatp2 was identified as the transporter responsible for the active hepatocellular pravastatin uptake.

Citing Articles

Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins.

Shi Z, Han S Heliyon. 2025; 11(1):e41629.

PMID: 39866414 PMC: 11761934. DOI: 10.1016/j.heliyon.2025.e41629.

Vitamin D Deficiency Impacts Exposure and Response of Pravastatin in Male Rats by Altering Hepatic OATPs.

Peng J, Yang G, Huang Z Front Pharmacol. 2022; 13:841954.

PMID: 35250587 PMC: 8892078. DOI: 10.3389/fphar.2022.841954.

Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.

Kawase A, Handa A, Iwaki M Eur J Drug Metab Pharmacokinet. 2016; 42(3):519-526.

PMID: 27511381 DOI: 10.1007/s13318-016-0367-9.

Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.

Garrison K, Sahin S, Benet L J Pharm Sci. 2015; 104(9):3229-35.

PMID: 26010239 PMC: 4536115. DOI: 10.1002/jps.24505.

Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Ronaldson P, Davis T Brain Res. 2015; 1623:39-52.

PMID: 25796436 PMC: 4569519. DOI: 10.1016/j.brainres.2015.03.018.

References

Saheki A, Terasaki T, Tamai I, Tsuji A . In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res. 1994; 11(2):305-11. DOI: 10.1023/a:1018975928974. View

Liman E, Tytgat J, Hess P . Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron. 1992; 9(5):861-71. DOI: 10.1016/0896-6273(92)90239-a. View

Jacquemin E, Hagenbuch B, Stieger B, Wolkoff A, Meier P . Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc Natl Acad Sci U S A. 1994; 91(1):133-7. PMC: 42900. DOI: 10.1073/pnas.91.1.133. View

Yamazaki M, Suzuki H, Sugiyama Y . Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res. 1996; 13(4):497-513. DOI: 10.1023/a:1016077517241. View

Ziegler K, Stunkel W . Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter. Biochim Biophys Acta. 1992; 1139(3):203-9. DOI: 10.1016/0925-4439(92)90135-a. View

Grundy S . HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med. 1988; 319(1):24-33. DOI: 10.1056/NEJM198807073190105. View

Yamazaki M, Suzuki H, Hanano M, Tokui T, Komai T, Sugiyama Y . Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol. 1993; 264(1 Pt 1):G36-44. DOI: 10.1152/ajpgi.1993.264.1.G36. View

Bossuyt X, Muller M, Hagenbuch B, Meier P . Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther. 1996; 276(3):891-6. View

Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H . Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem. 1997; 272(30):18526-9. DOI: 10.1074/jbc.272.30.18526. View

10.

Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M . Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem. 1998; 273(35):22395-401. DOI: 10.1074/jbc.273.35.22395. View

11.

Noe B, Hagenbuch B, Stieger B, Meier P . Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci U S A. 1997; 94(19):10346-50. PMC: 23365. DOI: 10.1073/pnas.94.19.10346. View

12.

Yamazaki M, Tokui T, Ishigami M, Sugiyama Y . Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system. Biopharm Drug Dispos. 1996; 17(9):775-89. DOI: 10.1002/(SICI)1099-081X(199612)17:9<775::AID-BDD990>3.0.CO;2-S. View

13.

van Vliet A, van Thiel G, Huisman R, Moshage H, Yap S, Cohen L . Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochim Biophys Acta. 1995; 1254(1):105-11. DOI: 10.1016/0005-2760(94)00176-y. View

14.

Komai T, Kawai K, Tokui T, Tokui Y, Kuroiwa C, Shigehara E . Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys. Eur J Drug Metab Pharmacokinet. 1992; 17(2):103-13. DOI: 10.1007/BF03188778. View

15.

Kullak-Ublick G, Hagenbuch B, Stieger B, Wolkoff A, Meier P . Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology. 1994; 20(2):411-6. View

16.

Li L, Lee T, Meier P, Ballatori N . Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem. 1998; 273(26):16184-91. DOI: 10.1074/jbc.273.26.16184. View

17.

Kouzuki H, Suzuki H, Ito K, Ohashi R, Sugiyama Y . Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes. J Pharmacol Exp Ther. 1999; 288(2):627-34. View

18.

Yamazaki M, Akiyama S, Niinuma K, Nishigaki R, Sugiyama Y . Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. Drug Metab Dispos. 1997; 25(10):1123-9. View

19.

Komai T, Shigehara E, Tokui T, Koga T, Ishigami M, Kuroiwa C . Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem Pharmacol. 1992; 43(4):667-70. DOI: 10.1016/0006-2952(92)90228-b. View

20.

Goldin A . Maintenance of Xenopus laevis and oocyte injection. Methods Enzymol. 1992; 207:266-79. DOI: 10.1016/0076-6879(92)07017-i. View